New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

by Center for Genomic RegulationCredit: Eva Novoa/Center for Genomic Regulation (CRG)Ribonucleic acid (RNA) molecules are present in all living cells, with different types of RNA having different jobs
World medicine December 05,2023
tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

tRNA biomarkers for cancer diagnosis and prognosis enabled by new method

by Center for Genomic RegulationCredit: Eva Novoa/Center for Genomic Regulation (CRG)Ribonucleic acid (RNA) molecules are present in all living cells, with different types of RNA having different jobs
World medicine December 05,2023
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

by Impact Journals LLCCytokine expression and cell viability upon mRNA silencing of STAT3 isoforms. Credit: 2023 Shamir et al.A new research paper was published inOncotarget's, titled "
World medicine December 05,2023
Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

Differential silencing of STAT3 isoforms leads to changes in STAT3 activation

by Impact Journals LLCCytokine expression and cell viability upon mRNA silencing of STAT3 isoforms. Credit: 2023 Shamir et al.A new research paper was published inOncotarget's, titled "
World medicine December 05,2023
Catching up with SOLUS: A new diagnostic approach for breast cancer

Catching up with SOLUS: A new diagnostic approach for breast cancer

byCORDISCredit: CordisBreast cancer diagnosis is an area that is constantly evolving, with new innovations emerging to improve patient outcomes. TheSOLUSproject is one such innovativ
World medicine December 05,2023
Catching up with SOLUS: A new diagnostic approach for breast cancer

Catching up with SOLUS: A new diagnostic approach for breast cancer

byCORDISCredit: CordisBreast cancer diagnosis is an area that is constantly evolving, with new innovations emerging to improve patient outcomes. TheSOLUSproject is one such innovativ
World medicine December 05,2023
Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

by Lori SolomonMaintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the Amer
World medicine December 05,2023
Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

Selinexor found to increase progression-free survival for endometrial cancer with TP53 mutations

by Lori SolomonMaintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the Amer
World medicine December 05,2023
New insights into how RNA modification promotes pancreatic cancer

New insights into how RNA modification promotes pancreatic cancer

byChinese Academy of SciencesLINC00901 regulates MYC signaling pathway. Credit:Genes & Diseases(2022). DOI: 10.1016/j.gendis.2022.02.014Chemical modifications of RNA molecules, s
World medicine December 05,2023
New insights into how RNA modification promotes pancreatic cancer

New insights into how RNA modification promotes pancreatic cancer

byChinese Academy of SciencesLINC00901 regulates MYC signaling pathway. Credit:Genes & Diseases(2022). DOI: 10.1016/j.gendis.2022.02.014Chemical modifications of RNA molecules, s
World medicine December 05,2023
RNA stability may play a role in prostate cancer

RNA stability may play a role in prostate cancer

by Sabrina Richards,Fred Hutchinson Cancer CenterGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112840Mutations in a genetic region that regulates RNA stab
World medicine December 05,2023
RNA stability may play a role in prostate cancer

RNA stability may play a role in prostate cancer

by Sabrina Richards,Fred Hutchinson Cancer CenterGraphical abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112840Mutations in a genetic region that regulates RNA stab
World medicine December 05,2023
RAGE as a driver of cell plasticity in aggressive subtype of triple-negative breast cancer

RAGE as a driver of cell plasticity in aggressive subtype of triple-negative breast cancer

by Vall d'Hebron Institute of OncologyRAGE signaling drives cell plasticity and invasion in TNBC cells.ARepresentative images showing morphological differences of MDA-MB-231 cells afte
World medicine December 05,2023
RAGE as a driver of cell plasticity in aggressive subtype of triple-negative breast cancer

RAGE as a driver of cell plasticity in aggressive subtype of triple-negative breast cancer

by Vall d'Hebron Institute of OncologyRAGE signaling drives cell plasticity and invasion in TNBC cells.ARepresentative images showing morphological differences of MDA-MB-231 cells afte
World medicine December 05,2023
Q&A: Merkel cell carcinoma

Q&A: Merkel cell carcinoma

by Catherine DegesysCredit: Unsplash/CC0 Public DomainI recently heard about a type of skin cancer called Merkel cell carcinoma. I'm not familiar with this condition. Can you explain what it is? D
Q & A December 05,2023
Q&A: Merkel cell carcinoma

Q&A: Merkel cell carcinoma

by Catherine DegesysCredit: Unsplash/CC0 Public DomainI recently heard about a type of skin cancer called Merkel cell carcinoma. I'm not familiar with this condition. Can you explain what it is? D
Q & A December 05,2023
Q&A: Cancer of the nerve cells

Q&A: Cancer of the nerve cells

by Dr. Stephanie PolitesCredit: Pixabay/CC0 Public DomainMy 4-year-old niece recently was diagnosed with neuroblastoma after not feeling well for a few weeks. Her parents noticed her belly was swollen
Q & A December 05,2023
Q&A: Cancer of the nerve cells

Q&A: Cancer of the nerve cells

by Dr. Stephanie PolitesCredit: Pixabay/CC0 Public DomainMy 4-year-old niece recently was diagnosed with neuroblastoma after not feeling well for a few weeks. Her parents noticed her belly was swollen
Q & A December 05,2023
Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics

Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics

by Justin Jackson , Medical XpressSingle-cell RNA-Seq analysis of monocytes/macrophages cluster in PTEN/p53-null breast tumors with catalytic isoform-specific PI3K deletion. Single-cell RNA-Seq analys
World medicine December 05,2023
Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics

Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics

by Justin Jackson , Medical XpressSingle-cell RNA-Seq analysis of monocytes/macrophages cluster in PTEN/p53-null breast tumors with catalytic isoform-specific PI3K deletion. Single-cell RNA-Seq analys
World medicine December 05,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com